Internet-delivered CBT for Irritable Bowel Syndrome

July 27, 2010 updated by: Karolinska Institutet

Internet-delivered Exposure and Mindfulness Based Therapy for Irritable Bowel Syndrome - A Randomized Controlled Trial

The aim of this study is to investigate the efficacy of a 10 week Internet-delivered CBT treatment for patients diagnosed with IBS. The patients' work with the treatment and is supported through online contact with a therapist.

Approximately 86 patients will be included in the study and randomized to either condition.

All included patients are assessed one week before the treatment starts. After 10 weeks (post treatment). Follow-up assessments are conducted at 3 and 12 months follow-up after treatment.

Patients in treatment condition are hypothesized to experience significant reduction IBS symptoms, societal costs and quality of life compared to patients on waiting list.

Study Overview

Study Type

Interventional

Enrollment (Actual)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 141 86
        • Internetpsykatrienheten, M46, Psykiatri sydväst

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of IBS given by physician
  • At screening fulfilling Rome III-criteria for IBS

Exclusion Criteria:

  • Severe depression
  • Suicidal ideation
  • Presence of unexplained IBS alarm symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Attention control
Weekly support from therapist without CBT-interventions
Weekly therapist support without CBT-interventions
Experimental: Internet CBT
Internet-delivered cognitive behavioral therapy with therapist support
Internet-delivered cognitive behavioral therapy with therapist support.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastrointestinal symptoms
Time Frame: One week before the treatment starts
Gastrointestinal Symptom rating scale (GSRS)
One week before the treatment starts
Gastrointestinal symptoms
Time Frame: 10 weeks after the treatment started
Gastrointestinal Symptom rating scale (GSRS)
10 weeks after the treatment started
Gastrointestinal symptoms
Time Frame: 3 months after the treatment ended
Gastrointestinal Symptom rating scale (GSRS)
3 months after the treatment ended
Gastrointestinal symptoms
Time Frame: One year after the treatment ended
Gastrointestinal Symptom rating scale (GSRS)
One year after the treatment ended

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health economic data
Time Frame: One week before the treatment starts
"Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry". In this questionnaire, patients register their monthly health care consumption (e.g. GP visits) as well as time spent in informal health enhancing activities (e.g. self-help groups and informal care from friends). In addition, work loss and work cutback both at work and in the domestic realm is measured.
One week before the treatment starts
Health economic data
Time Frame: 10 weeks after the treatment started
"Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry". In this questionnaire, patients register their monthly health care consumption (e.g. GP visits) as well as time spent in informal health enhancing activities (e.g. self-help groups and informal care from friends). In addition, work loss and work cutback both at work and in the domestic realm is measured.
10 weeks after the treatment started
Health economic data
Time Frame: 3 months after the treatment ended
"Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry". In this questionnaire, patients register their monthly health care consumption (e.g. GP visits) as well as time spent in informal health enhancing activities (e.g. self-help groups and informal care from friends). In addition, work loss and work cutback both at work and in the domestic realm is measured.
3 months after the treatment ended
Health economic data
Time Frame: One year after the treatment ended
"Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry". In this questionnaire, patients register their monthly health care consumption (e.g. GP visits) as well as time spent in informal health enhancing activities (e.g. self-help groups and informal care from friends). In addition, work loss and work cutback both at work and in the domestic realm is measured.
One year after the treatment ended
Quality of life
Time Frame: One week before the treatment starts
The Irritable Bowel Syndrome Quality of Life Instrument
One week before the treatment starts
Quality of life
Time Frame: 10 weeks after the treatment started
The Irritable Bowel Syndrome Quality of Life Instrument
10 weeks after the treatment started
Quality of life
Time Frame: 3 months after the treatment ended
The Irritable Bowel Syndrome Quality of Life Instrument
3 months after the treatment ended
Quality of life
Time Frame: One year after the treatment ended
The Irritable Bowel Syndrome Quality of Life Instrument
One year after the treatment ended
Gastrointestinal symptom-specific anxiety
Time Frame: One week before the treatment starts
Visceral Sensitivity Index
One week before the treatment starts
Gastrointestinal symptom-specific anxiety
Time Frame: 10 weeks after the treatment started
Visceral Sensitivity Index
10 weeks after the treatment started
Gastrointestinal symptom-specific anxiety
Time Frame: 3 months after the treatment ended
Visceral Sensitivity Index
3 months after the treatment ended
Gastrointestinal symptom-specific anxiety
Time Frame: One year after the treatment ended
Visceral Sensitivity Index
One year after the treatment ended
Depressive symptoms
Time Frame: One week before the treatment starts
The Montgomery Åsberg Depression Rating Scale
One week before the treatment starts
Depressive symptoms
Time Frame: 10 weeks after the treatment started
The Montgomery Åsberg Depression Rating Scale
10 weeks after the treatment started
Depressive symptoms
Time Frame: 3 months after the treatment ended
The Montgomery Åsberg Depression Rating Scale
3 months after the treatment ended
Depressive symptoms
Time Frame: One year after the treatment ended
The Montgomery Åsberg Depression Rating Scale
One year after the treatment ended
Functional impairments in work, social and family life
Time Frame: One week before the treatment starts
Sheenan Disability Scale (DSD)
One week before the treatment starts
Functional impairments in work, social and family life
Time Frame: 10 weeks after the treatment started
Sheenan Disability Scale (DSD)
10 weeks after the treatment started
Functional impairments in work, social and family life
Time Frame: 3 months after the treatment ended
Sheenan Disability Scale (DSD)
3 months after the treatment ended
Functional impairments in work, social and family life
Time Frame: One year after the treatment ended
Sheenan Disability Scale (DSD)
One year after the treatment ended

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2008

Primary Completion (Actual)

June 1, 2010

Study Completion (Actual)

June 1, 2010

Study Registration Dates

First Submitted

July 26, 2010

First Submitted That Met QC Criteria

July 27, 2010

First Posted (Estimate)

July 28, 2010

Study Record Updates

Last Update Posted (Estimate)

July 28, 2010

Last Update Submitted That Met QC Criteria

July 27, 2010

Last Verified

July 1, 2010

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Irritable Bowel Syndrome

Clinical Trials on Therapist support

3
Subscribe